Abstract
Metal and metal sulfide clusters embedded in polymeric matrices represents a novel nanostructured material class. These materials combine optical transparency to magnetism, luminescence, UV-visible absorption, thermochromism, etc. leaving to unique functional materials that can be conveniently exploited for a number of applications in different technological fields. A really effective synthesis route for these materials is represented by the thermal decomposition of mercaptide molecules dissolved in polymer. Mercaptides can be dissolved/dispersed in polymers and thermally degraded at temperatures compatible with polymer stability (100°-250°C), generating metal atoms or metal sulfide molecules that leave to very small nanoparticles by clustering. Mercaptide synthesis, blending with polymers, and thermal decomposition are quite simple and general operations, consequently this approach can be easily applied for the preparation of a variety of nanocomposite systems. In this review, we present some fundamental aspects related to the chemistry of mercaptides (synthesis), the calorimetric study of their thermolysis process, the main techniques for nanocomposite characterization, and a short description of material applications. This article also includes recent patent coverage.
Keywords: Mercaptides, thermolysis, metal cluster, nanocomposites
Recent Patents on Materials Science
Title: Synthesis of Polymer-Embedded Metal, Semimetal, or Sulfide Clusters by Thermolysis of Mercaptide Molecules Dissolved in Polymers
Volume: 1 Issue: 1
Author(s): Gianfranco Carotenuto, Luigi F. Nicolais and Francesca Nicolais
Affiliation:
Keywords: Mercaptides, thermolysis, metal cluster, nanocomposites
Abstract: Metal and metal sulfide clusters embedded in polymeric matrices represents a novel nanostructured material class. These materials combine optical transparency to magnetism, luminescence, UV-visible absorption, thermochromism, etc. leaving to unique functional materials that can be conveniently exploited for a number of applications in different technological fields. A really effective synthesis route for these materials is represented by the thermal decomposition of mercaptide molecules dissolved in polymer. Mercaptides can be dissolved/dispersed in polymers and thermally degraded at temperatures compatible with polymer stability (100°-250°C), generating metal atoms or metal sulfide molecules that leave to very small nanoparticles by clustering. Mercaptide synthesis, blending with polymers, and thermal decomposition are quite simple and general operations, consequently this approach can be easily applied for the preparation of a variety of nanocomposite systems. In this review, we present some fundamental aspects related to the chemistry of mercaptides (synthesis), the calorimetric study of their thermolysis process, the main techniques for nanocomposite characterization, and a short description of material applications. This article also includes recent patent coverage.
Export Options
About this article
Cite this article as:
Carotenuto Gianfranco, Nicolais F. Luigi and Nicolais Francesca, Synthesis of Polymer-Embedded Metal, Semimetal, or Sulfide Clusters by Thermolysis of Mercaptide Molecules Dissolved in Polymers, Recent Patents on Materials Science 2008; 1 (1) . https://dx.doi.org/10.2174/1874464810801010001
DOI https://dx.doi.org/10.2174/1874464810801010001 |
Print ISSN 1874-4648 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4656 |
Related Articles
-
Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry Drosophila melanogaster in the Study of Human Neurodegeneration
CNS & Neurological Disorders - Drug Targets MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer’s Disease
Current Neurovascular Research Editorial [Hot Topic: Frontiers of Metabolomics – Going from Bench to Bedside (Guest Editor: Anders Nordstrom)]
Current Pharmaceutical Biotechnology Enzyme Inhibitors as the Attractive Targets for the Treatment of Various Diseases
Current Medicinal Chemistry Tolfenamic Acid Interrupts the De Novo Synthesis of the β-Amyloid Precursor Protein and Lowers Amyloid Beta Via a Transcriptional Pathway
Current Alzheimer Research RETRACTED: Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery
Central Nervous System Agents in Medicinal Chemistry Enhanced Transdermal Delivery of Epidermal Growth Factor Facilitated by Dual Peptide Chaperone Motifs
Protein & Peptide Letters Cardiac Remodeling and Exercise Training in Hypertension
Current Hypertension Reviews Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson’s Disease
Current Aging Science Exosomes: The Messengers of Health and Disease
Current Neuropharmacology Biomarker Validation of a New Case Definition of Menstrual Cycle-Associated Syndrome (MCAS) Opinion Paper
CNS & Neurological Disorders - Drug Targets Lipid Based Anti-Retroviral Nanocarriers: A Review of Current Literature and Ongoing Studies
Drug Delivery Letters Evaluation of microRNA Stability in Plasma and Serum from Healthy Dogs
MicroRNA Ageing as a Trait de Union Between Diabetes and Dementia for Frailty
CNS & Neurological Disorders - Drug Targets The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets In Silico ADME and QSAR Studies on a Set of Coumarin Derivatives As Acetylcholinesterase Inhibitors Against Alzheimer’s Disease: CoMFA, CoMSIA, Topomer CoMFA, and HQSAR
Letters in Drug Design & Discovery Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin RepairATION AND MYELIN REPAIR
CNS & Neurological Disorders - Drug Targets ROS1 Kinase Inhibitors for Molecular-Targeted Therapies
Current Medicinal Chemistry Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology